Sarandol, A. Et Al. 2007. Oxidative-antioxidative systems and their relation with serum S100B levels in patients with schizophrenia: Effects of short term antipsychotic treatment. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY , vol.31, no.6 , 1164-1169.

Sarandol, A., Kirli, S., Akkaya, C., Altin, A., Demirci, M., & Sarandol, E., (2007). Oxidative-antioxidative systems and their relation with serum S100B levels in patients with schizophrenia: Effects of short term antipsychotic treatment. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY , vol.31, no.6, 1164-1169.

Sarandol, ASLI Et Al. "Oxidative-antioxidative systems and their relation with serum S100B levels in patients with schizophrenia: Effects of short term antipsychotic treatment," PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY , vol.31, no.6, 1164-1169, 2007

Sarandol, ASLI Et Al. "Oxidative-antioxidative systems and their relation with serum S100B levels in patients with schizophrenia: Effects of short term antipsychotic treatment." PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY , vol.31, no.6, pp.1164-1169, 2007

Sarandol, A. Et Al. (2007) . "Oxidative-antioxidative systems and their relation with serum S100B levels in patients with schizophrenia: Effects of short term antipsychotic treatment." PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY , vol.31, no.6, pp.1164-1169.

@article{article, author={ASLI SARANDÖL Et Al. }, title={Oxidative-antioxidative systems and their relation with serum S100B levels in patients with schizophrenia: Effects of short term antipsychotic treatment}, journal={PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY}, year=2007, pages={1164-1169} }